Literature DB >> 4323443

Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses.

T J Smith, E L Buescher, F H Top, W A Altemeier, J M McCown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4323443     DOI： 10.1093/infdis/122.4.239

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  13 in total

1.  Immunization of mice against encephalomyocarditis virus. I. Purification, concentration, and inactivation of encephalomyocarditis virus.

Authors:  W J Bogaerts
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

2.  A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity.

Authors:  Kenta Matsuda; Stephen A Migueles; Jinghe Huang; Lyuba Bolkhovitinov; Sarah Stuccio; Trevor Griesman; Alyssa A Pullano; Byong H Kang; Elise Ishida; Matthew Zimmerman; Neena Kashyap; Kelly M Martins; Daniel Stadlbauer; Jessica Pederson; Andy Patamawenu; Nathaniel Wright; Tulley Shofner; Sean Evans; C Jason Liang; Julián Candia; Angelique Biancotto; Giovanna Fantoni; April Poole; Jon Smith; Jeff Alexander; Marc Gurwith; Florian Krammer; Mark Connors
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

3.  The nature of adenovirus persistence in human adenoid vegetations.

Authors:  V Snejdarová; V Vonka; L Kutinová; D Rezácová; V Chládek
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

Review 4.  Mucosal immunology.

Authors:  J Bienenstock; A D Befus
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

5.  Enteric immunization with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization.

Authors:  R M Scott; B A Dudding; S V Romano; P K Russell
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

6.  Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.

Authors:  B G Harvey; N R Hackett; T El-Sawy; T K Rosengart; E A Hirschowitz; M D Lieberman; M L Lesser; R G Crystal
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.

Authors:  Bo Peng; Liqun Rejean Wang; Victor Raúl Gómez-Román; Alberta Davis-Warren; David C Montefiori; V S Kalyanaraman; David Venzon; Jun Zhao; Elaine Kan; Thomas J Rowell; Krishna K Murthy; Indresh Srivastava; Susan W Barnett; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 8.  Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.

Authors:  L Jean Patterson; Marjorie Robert-Guroff
Journal:  Expert Opin Biol Ther       Date:  2008-09       Impact factor: 4.388

9.  Appearance of specific antibody-bearing cells in human bronchial mucosa after local immunization with bacterial vaccine.

Authors:  F Latil; D Vervloet; P Casanova; L Garbe; P Fuentes; N Wierzbicki; J Charpin
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

10.  Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus.

Authors:  T Kanesaki; B R Murphy; P L Collins; P L Ogra
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.